| Term 
 | Definition 
 
        | Pharmacology: Neurotoxic to dopaminergic neurons decreasing DA function 
 Effects: Parkinson's symptoms, decrease in cognition
 |  | 
        |  | 
        
        | Term 
 
        | Acetyl Choline Inhibitors |  | Definition 
 
        | Pharmacolgy: muscarinic an nicotinic acetyl choline receptor (mAChR and nAChR) competitive and noncompetitive antagonists 
 Effects:Increase in heart rate and decreased cognitive function
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Pharmacology: DA (Dopamine) and NE (norepinephrine) transporter inhibitor/releaser (through the transporter) 
 Effects:Increased heart rate (HR) and blood pressure (BP), addiction
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Pharmacology: Old (typical) - DA D2 antagonists, New (atypical) - D2 antagonists and 5-HT antagonists   Effects: Loss in cognition and Parkinsonian-like symptoms |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Pharmacology: mAChR antagonist 
 Effects: Decreased GI action, decreased saliva
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Pharamcology: GABA receptor agonist 
 Effects: Anti-convulsant, anxiolytic
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Pharmacology: GABA receptor allosteric modulator (noncompetitive agonist) 
 Effects: Anti-convulsant, anxionlytic
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Pharmacology: Atypical antipsychotic, D2 and 5-HT antagonist 
 Effects: Sedation, depression-like symptoms (acutely)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Pharmacology: Opiate receptor competitive agonist 
 Effects: Analgesia, constipation
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Pharmacology: Tricyclic   Effects: Sedation, constipation |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Pharmacology: "Classic benzodiazepine", allosteric modulator of GABA receptor 
 Effects: Anti-convulsant, anxiolytic
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Pharmacology: Blocks metabolism of acetylaldehyde by blocking acetylaldehyde dehydrogenase 
 Effects: Headache, facial flushing
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Pharmacology: SSRI that inhibits 5-HT reuptake 
 Effects: Insomnia, sexual disfunction
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Pharmacology: "Classic" antipsychotic, D2 antagonist   Effects: Treat schizophrenia, decreased cognition |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Pharmacology: NMDA (which mimics glutamate) receptor competitive antagonist 
 Effects: Analgesia, anesthesia
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Pharmacology: Is DA's precursor --> upregulates DA and its systems' activation 
 Effects: Short term can treat Parkinsons, long term use can cause schizophrenia
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Pharmacology: Inhibit activity of monoamine oxidase preventing the breakdown of monoamine NT's (DA, NE, 5-HT) 
 Effects: Addiction, insomnia
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Pharmacology: Enhances 5-HT release and inhibits 5-HT reuptake, enhances DA release 
 Effects: Increased HR, anxiogenesis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Pharmacology: µ-opioid agonist   Effects: Analgesis, depressed breathing |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Pharmacology: DA re-uptake inhbitor of transporter 
 Effects: Increase in concentration, headache
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Pharmacology: GABA receptor allosteric modulator/noncompetitive agonist 
 Effects: Anticonvulsant, anxiolytic
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Pharmacology: Opiate receptor antagonist   Effects: Blocks alcohol's "euphoria", lower paintolerance |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Pharmacology: SSRI   Effects: Insomnia, sexual disfunction |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Pharmacology: B-andrenoceptor antagonist (blocks effects of adrenogens like epinephrine and NE) 
 Effects: Lowers BP, anxiolytic
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Pharmacology: 5-HT2A competitive agonist 
 Effects: Increased HR, hallucinations
 |  | 
        |  | 
        
        | Term 
 
        | SSRI's (Selective Serotonin Reuptake Inhibitors) |  | Definition 
 
        | Pharmacology: Inhibits 5-HT reuptake   Effects: Acute anxiogenesis, sexual disfunction |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Pharmacology:  Muscarinic AChR antagonist   Effects: Decreased GI activity, decreased saliva |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Pharmacology: SSRI   Effects: Insomnia, sexual disfunction |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Pharmacology: ACh esterase inhibitor (don't break down ACh --> its effects are upregulated)   Effects:  Increased digestion, increased  HR |  | 
        |  | 
        
        | Term 
 
        | Tricyclic Antidepressants |  | Definition 
 
        | Pharmacology: 5-HT and NE reuptake inhibitors   Effects: Sedation, constipation |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Pharmacology: 5-HT and NE reuptake inhibitor 
 Effects: Acute depression-like symptoms, anxyolitic
 |  | 
        |  |